@FierceBiotech: Pfizer updates late-stage pipeline prospects and discards. Story | Follow @FierceBiotech
@JohnCFierce: Pfizer has been stirring some heated criticism in the UK. Sandwich decision was politically awkward for the prime minister. Story | Follow @JohnCFierce
> Dendreon has confirmed that it is moving its headquarters building into a 42-story office building in downtown Seattle. Story
> Regulators' lengthy anti-trust review has held up the planned animal health joint venture being set up by Merck and Sanofi-Aventis. Report
> ProteoMonitor tells us about some fascinating research going on between scientists at Thermo Fisher Scientific's BRIMS Center and Massachusetts General Hospital to identify protein biomarkers linked to stroke. Story
> Pharmacyclics has suspended further advancement of PCI-45292, a Btk inhibitor. The company hopes to have a new clinical development candidate identified within approximately 6 months. Story
> The European Medicines Agency (EMA) is looking for public comment on the first clinical biomarker the agency has approved for use in humans, according to a report in PharmaTimes. Story
> The Oklahoma Daily, the University of Oklahoma's student newspaper, tells us about the school's college of pharmacy and its acquisition of a biomarker generator from Tennessee-based Advanced Biomarker Technologies. The paper says OU "will be the first institution in the world to install and use a biomarker generator for help in imaging and diagnosing diseases." Report
> After the visible symptoms associated with Lyme disease (a bulls-eye rash) go away, some patients continue to suffer extreme tiredness--a symptom that is often mistaken for chronic fatigue syndrome. So, how can a physician tell the difference between the two? A new study reports that protein biomarkers in spinal fluid can clear up the confusion. Story
And Finally... Investigators say that they have new evidence that shows there's a greater risk that Alzheimer's is passed from a mother to her children than from a father. Story